Day: May 27, 2025

Notes now convertible into series A4 preferred shares | $1.5 million of notes converted HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT; “Fr8Tech” or the “Company”), a logistics management innovation company, offering a diverse portfolio of technology-driven solutions, today announced it has entered into an Amendment and Exchange Agreement (the “Exchange Agreement”) with one of its accredited investors, under the Securities Purchase Agreement, dated April 29, 2025, (the “Facility”). Net proceeds from the $20 million Facility are designated for the purchase of OFFICIAL TRUMP coins. Under the terms of the Exchange Agreement, the investor will exchange certain previously issued senior convertible notes for Series A4 preferred shares (the “New Preferred Shares”) of the Company. Concurrently, the accredited...

Not for dissemination in the United States of America VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — Aja Health and Wellness Inc. (“Aja” or the “Company”) (TSXV:Aja) announces that its wholly owned subsidiary Aja Therapeutics Inc. (“ATI“) is launching a nasal spray product for migraine headache relief. ATI’s research and development lab in Atlanta, Georgia has concluded initial testing of the nasal spray and anticipates the product will be released for retail sale in the United States on May 28, 2025. The nasal spray will be available for purchase by United States residents at www.easemyheadache.com. “There are a reported 32 million migraine sufferers in the United States who are looking for an alternative to harsh chemicals for migraine prevention and treatment. ATI’s proprietary...

New York, NY, May 27, 2025 (GLOBE NEWSWIRE) — Kochav Defense Acquisition Corp. (NASDAQ: KCHVU) (the “Company”) today announced the pricing of its initial public offering of 22,000,000 units at a price of $10.00 per unit. The Company’s units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “KCHVU” beginning May 28, 2025. Each unit to be issued in the offering consists of one Class A ordinary share of the Company and one right to receive one seventh (1/7) of a Class A ordinary share upon the consummation of the Company’s initial business combination. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols “KCHV” and “KCHVR,” respectively. The closing of the offering is expected to...

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) — Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) announced today that each of the nominee directors listed in the management information circular of the Company dated March 10, 2025 was elected as a director of the Company (a “Director”) at the annual meeting (the “Meeting”) of the holders of common shares of the Company (the “Common Shares”) held today. The number of Common Shares voted in person or by proxy for the election of each Director or withheld was as indicated below:Name of Nominee Votes For % Votes Withheld %Heather Allen 33,842,993 99.86% 46,448 0.14%Dr. Louis Aronne 33,863,450 99.92% 25,991 0.08%Tania Clarke 33,885,796 99.99% 3,645 0.01%Diane Nyisztor 33,885,001 99.99% 4,440 0.01%Michael Pilato 33,858,957 99.91% 30,484 0.09%Timothy...

New partnership brings Yerbaé’s functional beverages to Guckenheimer’s national café & market business and expands reach for Safety Shot at the conclusion of the companies’ merger SCOTTSDALE, Ariz., May 27, 2025 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (“SHOT”, “Safety Shot”, or the “Company”), a wellness and dietary supplement company, announces its acquisition partner, Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based functional beverage company has entered into a strategic distribution partnership with Guckenheimer, a premier national food service operator. With over 480 market and café locations across 34 states, Guckenheimer serves some of the most recognizable companies, including Google, Texas Instruments, and Duolingo. This partnership significantly expands...

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) — Mercer International Inc. (“Mercer” or the “Company”) (Nasdaq: MERC), a global forest products company, today released its 2024 Sustainability Report, Fit for Future: Transition and Transformation. The report outlines, among other things, the Company’s progress towards its 2030 sustainability goals. Juan Carlos Bueno, President and CEO, stated: “In 2024, we applied the same operational discipline to our sustainability efforts that we bring to all areas of our business. We focused on where Mercer can make the most meaningful contribution—reducing emissions at the source, improving resource efficiency, and advancing renewable bioproducts. These steps reflect our learning and commitment to a long-term, practical impact that we believe will add value to our overall business.” Bill Adams, Chief...

The final short form prospectus is accessible through SEDAR+ NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, May 27, 2025 (GLOBE NEWSWIRE) — Alaris Equity Partners Income Trust (“Alaris” or the “Trust“) (TSX: AD.UN) is pleased to announce today that it has filed, and obtained a receipt for, a final short form prospectus (the “Prospectus“) in each of the provinces of Canada, other than Québec, with respect to the previously announced bought deal offering of $80 million principal amount of 6.50% convertible unsecured senior debentures (the “Debentures”) through a syndicate of underwriters (the “Underwriters“) led by National Bank Financial Inc., CIBC Capital Markets and Desjardins...

Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to bringing important new treatment options to underserved patient populationsTEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries, Ltd. (NYSE and TASE: TEVA) today announced that the US Food and Drug Administration (FDA) granted Fast Track designation for investigational TEV-53408, an anti-IL-15 antibody, for the treatment of people with celiac disease on a gluten-free diet. TEV-53408 is currently being evaluated in a Phase 2a trial to assess the efficacy and safety in adults with celiac disease. Fast Track is an FDA process designed to facilitate development...